年表作成・共有サービス - pastport

https://www.pharmasources.com/products/human-vaccine-267222.html

Vibalogics, a global contract development and manufacturing organization (CDMO) specializing in the production of oncolytic viruses, viral vectors, and vaccine virotherapy products, has made key senior U.S.-based hires to the global leadership team.

Roger Lias joins Vibalogics as chief commercial officer with responsibility for global oversight of the company’s business development, sales and program management divisions. Mr. Lias will be responsible for harmonizing the approach for all customer interactions worldwide and growing business at both the Boxborough, MA and Cuxhaven, Germany facilities.

He brings a wealth of experience in the biologics CDMO arena, having held senior commercial roles at Lonza and Diosynth before being a member of the founding management teams at KBI Biopharma, Cytovance Biologics and Eden Biodesign.

More recently, Mr. Lias served as CEO at Avid Bioservices and Stelis Biopharma, where in both instances he was responsible for the successful transition to dedicated CDMO models.

Mr. Lias joins industry veterans Joe Sinclair who recently joined the company as vice president of business development and corporate strategy, and Matt Codd who was recently appointed as vice president of global sales.